1288 related articles for article (PubMed ID: 15781103)
1. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome.
Tarr PI; Gordon CA; Chandler WL
Lancet; 2005 Mar 19-25; 365(9464):1073-86. PubMed ID: 15781103
[TBL] [Abstract][Full Text] [Related]
2. [Post-diarrheal haemolytic uremic syndrome: when shall we consider it? Which follow-up?].
Bertholet-Thomas A; Ranchin B; King LA; Bacchetta J; Belot A; Gillet Y; Collardeau-Frachon S; Cochat P
Arch Pediatr; 2011 Jul; 18(7):823-30. PubMed ID: 21571510
[TBL] [Abstract][Full Text] [Related]
3. Shiga toxin-associated hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: distinct mechanisms of pathogenesis.
Tarr PI
Kidney Int Suppl; 2009 Feb; (112):S29-32. PubMed ID: 19180128
[TBL] [Abstract][Full Text] [Related]
4. Management of diarrhea-associated hemolytic uremic syndrome in children.
Iijima K; Kamioka I; Nozu K
Clin Exp Nephrol; 2008 Feb; 12(1):16-9. PubMed ID: 18175052
[TBL] [Abstract][Full Text] [Related]
5. Desperately seeking diarrhoea: outbreak of haemolytic uraemic syndrome caused by emerging sorbitol-fermenting shiga toxin-producing Escherichia coli O157:H-, Germany, 2009.
Nielsen S; Frank C; Fruth A; Spode A; Prager R; Graff A; Plenge-Bönig A; Loos S; Lütgehetmann M; Kemper MJ; Müller-Wiefel DE; Werber D
Zoonoses Public Health; 2011 Dec; 58(8):567-72. PubMed ID: 21824358
[TBL] [Abstract][Full Text] [Related]
6. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
[TBL] [Abstract][Full Text] [Related]
7. Haemolytic uraemic syndrome and Shiga toxin-producing Escherichia coli infection in children in France. The Société de Néphrologie Pédiatrique.
Decludt B; Bouvet P; Mariani-Kurkdjian P; Grimont F; Grimont PA; Hubert B; Loirat C
Epidemiol Infect; 2000 Apr; 124(2):215-20. PubMed ID: 10813145
[TBL] [Abstract][Full Text] [Related]
8. Paediatric haemolytic uraemic syndrome related to Shiga toxin-producing
Bruyand M; Mariani-Kurkdjian P; Le Hello S; King LA; Van Cauteren D; Lefevre S; Gouali M; Jourdan-da Silva N; Mailles A; Donguy MP; Loukiadis E; Sergentet-Thevenot D; Loirat C; Bonacorsi S; Weill FX; De Valk H;
Euro Surveill; 2019 Feb; 24(8):. PubMed ID: 30808442
[TBL] [Abstract][Full Text] [Related]
9. Infection by Shiga toxin-producing Escherichia coli: an overview.
Karmali MA
Mol Biotechnol; 2004 Feb; 26(2):117-22. PubMed ID: 14764937
[TBL] [Abstract][Full Text] [Related]
10. A clinical and bacteriological study of children suffering from haemolytic uraemic syndrome in Tucuman, Argentina.
Miceli S; Jure MA; de Saab OA; de Castillo MC; Rojas S; de Holgado AP; de Nader OM
Jpn J Infect Dis; 1999 Apr; 52(2):33-7. PubMed ID: 10816611
[TBL] [Abstract][Full Text] [Related]
11. An epidemiologic surveillance of Shiga-like toxin-producing Escherichia coli infection in Argentinean children: risk factors and serum Shiga-like toxin 2 values.
López EL; Contrini MM; Glatstein E; Ayala SG; Santoro R; Ezcurra G; Teplitz E; Matsumoto Y; Sato H; Sakai K; Katsuura Y; Hoshide S; Morita T; Harning R; Brookman S
Pediatr Infect Dis J; 2012 Jan; 31(1):20-4. PubMed ID: 21829137
[TBL] [Abstract][Full Text] [Related]
12. Enterohaemorrhagic Escherichia coli in human medicine.
Karch H; Tarr PI; Bielaszewska M
Int J Med Microbiol; 2005 Oct; 295(6-7):405-18. PubMed ID: 16238016
[TBL] [Abstract][Full Text] [Related]
13. Shopper cards data and storage practices for the investigation of an outbreak of Shiga-toxin producing Escherichia coli O157 infections.
Barret AS; Charron M; Mariani-Kurkdjian P; Gouali M; Loukiadis E; Poignet-Leroux B; Godron A; Gault G; Faure M; Mailles A;
Med Mal Infect; 2013 Sep; 43(9):368-73. PubMed ID: 23910937
[TBL] [Abstract][Full Text] [Related]
14. Shiga toxin-induced haemolytic uraemic syndrome and the role of antibiotics: a global overview.
Kakoullis L; Papachristodoulou E; Chra P; Panos G
J Infect; 2019 Aug; 79(2):75-94. PubMed ID: 31150744
[TBL] [Abstract][Full Text] [Related]
15. A verocytotoxin-producing E. coli outbreak with a surprisingly high risk of haemolytic uraemic syndrome, Denmark, September-October 2012.
Soborg B; Lassen SG; Müller L; Jensen T; Ethelberg S; Mølbak K; Scheutz F
Euro Surveill; 2013 Jan; 18(2):. PubMed ID: 23324425
[TBL] [Abstract][Full Text] [Related]
16. Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study.
Gerber A; Karch H; Allerberger F; Verweyen HM; Zimmerhackl LB
J Infect Dis; 2002 Aug; 186(4):493-500. PubMed ID: 12195376
[TBL] [Abstract][Full Text] [Related]
17. Hemolytic uremic syndrome due to Shiga toxin-producing Escherichia coli infection.
Bruyand M; Mariani-Kurkdjian P; Gouali M; de Valk H; King LA; Le Hello S; Bonacorsi S; Loirat C
Med Mal Infect; 2018 May; 48(3):167-174. PubMed ID: 29054297
[TBL] [Abstract][Full Text] [Related]
18. Bacterial genetic determinants of non-O157 STEC outbreaks and hemolytic-uremic syndrome after infection.
Wickham ME; Lupp C; Mascarenhas M; Vazquez A; Coombes BK; Brown NF; Coburn BA; Deng W; Puente JL; Karmali MA; Finlay BB
J Infect Dis; 2006 Sep; 194(6):819-27. PubMed ID: 16941350
[TBL] [Abstract][Full Text] [Related]
19. Shiga toxin-producing Escherichia coli O171:H25 strain isolated from a patient with haemolytic uraemic syndrome.
Lepšanović Z; Opačić D; Lazić S; Herpay M; Tóth S; Kostić M; Kucsera I
Acta Microbiol Immunol Hung; 2012 Jun; 59(2):215-24. PubMed ID: 22750781
[TBL] [Abstract][Full Text] [Related]
20. [Hemolytic uremic syndrome caused by Shiga-toxin-producing Escherichia coli].
Loirat C
Rev Prat; 2013 Jan; 63(1):11-6. PubMed ID: 23457821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
